isosorbide dinitrate has been researched along with Genetic Predisposition in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dries, DL; McNamara, D; Rame, JE; Sabolinski, ML; Tam, SW; Worcel, M; Wu, AH | 1 |
| Puckrein, G; Yancy, CW | 1 |
| Echols, MR; Yancy, CW | 1 |
| Hoover, EL | 1 |
| Sade, RM | 1 |
| Korsten, MA; Ma, JJ; Mei, QB; Qui, B | 1 |
1 review(s) available for isosorbide dinitrate and Genetic Predisposition
| Article | Year |
|---|---|
Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure.
Topics: Black or African American; Disease Progression; Drug Combinations; Endothelium, Vascular; Genetic Predisposition to Disease; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitric Oxide; Oxidative Stress; Patient Selection; Severity of Illness Index; Treatment Outcome; Vasodilator Agents | 2006 |
6 other study(ies) available for isosorbide dinitrate and Genetic Predisposition
| Article | Year |
|---|---|
Dysfunctional corin i555(p568) allele is associated with impaired brain natriuretic peptide processing and adverse outcomes in blacks with systolic heart failure: results from the Genetic Risk Assessment in Heart Failure substudy.
Topics: Black or African American; Cardiovascular Agents; Double-Blind Method; Drug Combinations; Female; Gene Frequency; Genetic Predisposition to Disease; Heart Failure, Systolic; Hospitalization; Humans; Hydralazine; Immunoassay; Isosorbide Dinitrate; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Mutation; Natriuretic Peptide, Brain; Phenotype; Proportional Hazards Models; Protein Processing, Post-Translational; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Serine Endopeptidases; Treatment Outcome; United States | 2009 |
Illuminating BiDil.
Topics: Black or African American; Drug Approval; Drug Combinations; Genetic Predisposition to Disease; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Politics; Public Policy; United States | 2005 |
BiDil's impact.
Topics: Black or African American; Drug Approval; Drug Combinations; Genetic Predisposition to Disease; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Risk; United States | 2005 |
There is no scientific rationale for race-based research.
Topics: Biomarkers; Biomedical Research; Black or African American; Clinical Trials as Topic; Drug Combinations; Genetic Predisposition to Disease; Genetic Variation; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Prejudice; Racial Groups; United States | 2007 |
What's right (and wrong) with racially stratified research and therapies.
Topics: Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Biomedical Research; Black or African American; Drug Approval; Drug Combinations; Drug Industry; Genetic Predisposition to Disease; Genetic Variation; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Prejudice; Racial Groups; Randomized Controlled Trials as Topic; United States; United States Food and Drug Administration | 2007 |
Susceptibility to cerulein-induced pancreatitis in inducible nitric oxide synthase-deficient mice.
Topics: Acute Disease; Amylases; Animals; Ceruletide; Genetic Predisposition to Disease; Injections, Intraperitoneal; Isosorbide Dinitrate; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neutrophils; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Pancreatitis; Peroxidase | 2001 |